Modafinil exerts a dose-dependent antiepileptic effect mediated by adrenergic α1 and histaminergic H1 receptors in mice

Neuropharmacology

Volumn 53, Issue 4, 2007, Pages 534-541

  Chen, C R ^a   Qu, W M ^b   Qiu, M H ^a   Xu, X H ^a,b   Yao, M H ^a   Urade, Y ^b   Huang, Z L ^a,b  

^a FUDAN UNIVERSITY   (China)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Maximal electroshock; Pentylenetetrazol; Pyrilamine; Seizure; Terazosin

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA 1 ADRENERGIC RECEPTOR; HALOPERIDOL; HISTAMINE H1 RECEPTOR; MEPYRAMINE; MODAFINIL; PENTETRAZOLE; TERAZOSIN; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ELECTRIC SHOCK; ELECTROENCEPHALOGRAM; EPILEPSY; HINDLIMB; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BENZHYDRYL COMPOUNDS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; ELECTROSHOCK; EPILEPSY; MALE; MICE; MICE, INBRED STRAINS; NEUROPROTECTIVE AGENTS; PENTYLENETETRAZOLE; SEIZURES;

EID: 34548019268     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.017     Document Type: Article

References (51)

1. Baf M.H., Subhash M.N., Lakshmana K.M., and Rao B.S. Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine. Neurochem. Res. 19 (1994) 1139-1143
2. Baf M.H., Subhash M.N., Lakshmana K.M., and Rao B.S. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem. Int. 24 (1994) 67-72
3. Chauvel P., and Trottier S. Role of noradrenergic ascending system in extinction of epileptic phenomena. Adv. Neurol. 44 (1986) 475-487
4. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., and Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
5. Chen Z., Li Z., Sakurai E., Izadi Mobarakeh J., Ohtsu H., Watanabe T., Iinuma K., and Yanai K. Chemical kindling induced by pentylenetetrazol in histamine H(1) receptor gene knockout mice (H(1)KO), histidine decarboxylase-deficient mice (HDC(-/-)) and mast cell-deficient W/W(v) mice. Brain Res. 968 (2003) 162-166
6. de Saint Hilaire Z., Orosco M., Rouch C., Blanc G., and Nicolaidis S. Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats. Neuroreport 12 (2001) 3533-3537
7. Duteil J., Rambert F.A., Pessonnier J., Hermant J.F., Gombert R., and Assous E. Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals. Eur. J. Pharmacol. 180 (1990) 49-58
8. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F., and Fuxe K. The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport 8 (1997) 2883-2887
9. Ferraro L., Antonelli T., O'Connor W.T., Tanganelli S., Rambert F.A., and Fuxe K. The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci. Lett. 253 (1998) 135-138
10. Ferraro L., Antonelli T., Tanganelli S., O'Connor W.T., Perez de la Mora M., Mendez-Franco J., Rambert F.A., and Fuxe K. The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20 (1999) 346-356
11. Fredholm B.B., Bättig K., Holmėn J., Nehlig A., and Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51 (1999) 83-133
12. Gallopin T., Luppi P.H., Rambert F.A., Frydman A., and Fort P. Effect of the wake-promoting agent modafinil on sleep-promoting neurons from the ventrolateral preoptic nucleus: an in vitro pharmacologic study. Sleep 27 (2004) 19-25
13. Getova D., Froestl W., and Bowery N.G. Effects of GABAB receptor antagonism on the development of pentylenetetrazol-induced kindling in mice. Brain Res. 809 (1998) 182-188
14. Hansen S.L., Sperling B.B., and Sanchez C. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 105-113
15. Hong Z.Y., Huang Z.L., Qu W.M., and Eguchi N. Orexin A promotes histamine, but not norepinephrine or serotonin, release in frontal cortex of mice. Acta Pharmacol. Sin. 26 (2005) 155-159
16. Hong Z.Y., Huang Z.L., Qu W.M., Eguchi N., Urade Y., and Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 92 (2005) 1542-1549
17. Huang Z.L., Qu W.M., Li W.D., Mochizuki T., Eguchi N., Watanabe T., Urade Y., and Hayaishi O. Arousal effect of orexin A depends on activation of the histaminergic system. Proc. Natl. Acad. Sci. USA 98 (2001) 9965-9970
18. Huang Z.L., Mochizuki T., Qu W.M., Hong Z.Y., Watanabe T., Urade Y., and Hayaishi O. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 103 (2006) 4687-4692
19. Huang Z.L., Urade Y., and Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 7 (2007) 33-38
20. Ishizuka T., Sakamoto Y., Sakurai T., and Yamatodani A. Modafinil increases histamine release in the anterior hypothalamus of rats. Neurosci. Lett. 339 (2003) 143-146
21. Kamei C., Ishizawa K., Kakinoki H., and Fukunaga M. Histaminergic mechanisms in amygdaloid-kindled seizures in rats. Epilepsy Res. 30 (1998) 187-194
22. Kamei C., Ohuchi M., Sugimoto Y., and Okuma C. Mechanism responsible for epileptogenic activity by first-generation H1-antagonists in rats. Brain Res. 887 (2000) 183-186
23. Kaneko Y., Shimada K., Saitou K., Sugimoto Y., and Kamei C. The mechanism responsible for the drowsiness caused by first generation H1 antagonists on the EEG pattern. Methods Find. Exp. Clin. Pharmacol. 22 (2000) 163-168
24. Krahl S.E., Clark K.B., Smith D.C., and Browning R.A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 39 (1998) 709-714
25. Leurs R., Blandina P., Tedford C., and Timmerman H. Therapeutic potential of histamine H3 receptor agonists and antagonists. Trends Pharmacol. Sci. 19 (1998) 177-183
26. Lin J.S., Sakai K., and Jouvet M. Hypothalamo-preoptic histaminergic projections in sleep-wake control in the cat. Eur. J. Neurosci. 6 (1994) 618-625
27. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., Johnson R., Livni E., Spencer T.J., Bonab A.A., Miller G.M., and Fischman A.J. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J. Pharmacol. Exp. Ther. 319 (2006) 561-569
28. Malow B.A., Kushwaha R., Lin X., Morton K.J., and Aldrich M.S. Relationship of interictal epileptiform discharges to sleep depth in partial epilepsy. Electroencephalogr. Clin. Neurophysiol. 102 (1997) 20-26
29. Manni R., Zambrelli E., Bellazzi R., and Terzaghi M. The relationship between focal seizures and sleep: an analysis of the cyclic alternating pattern. Epilepsy Res. 67 (2005) 73-80
30. Meshkibaf M.H., Subhash M.N., Lakshmana K.M., and Rao B.S. Effect of chronic administration of phenytoin on regional monoamine levels in rat brain. Neurochem. Res. 20 (1995) 773-778
31. Mignot E., Taheri S., and Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat. Neurosci. 5 Suppl. (2002) 1071-1075
32. Murillo-Rodriguez E., Haro R., Palomero-Rivero M., Millan-Aldaco D., and Drucker-Colin R. Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats. Behav. Brain Res. 176 (2007) 353-357
33. Nishida N., Huang Z.L., Mikuni N., Miura Y., Urade Y., and Hashimoto N. Deep brain stimulation of the posterior hypothalamus activates the histaminergic system to exert antiepileptic effect in rat pentylenetetrazol model. Exp. Neurol. 205 (2007) 132-144
34. Romanelli F., and Smith K.M. Clinical effects and management of methamphetamine abuse. Pharmacotherapy 26 (2006) 1148-1156
35. Sands S.A., Guerra V., and Morilak D.A. Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid. Neuropsychopharmacology 22 (2000) 27-35
36. Scammell T.E., Estabrooke I.V., McCarthy M.T., Chemelli R.M., Yanagisawa M., Miller M.S., and Saper C.B. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. J. Neurosci. 20 (2000) 8620-8628
37. Scherkl R., Hashem A., and Frey H.H. Histamine in brain-its role in regulation of seizure susceptibility. Epilepsy Res. 10 (1991) 111-118
38. Shi L.H., Luo F., Woodward D., and Chang J.Y. Deep brain stimulation of the substantia nigra pars reticulata exerts long lasting suppression of amygdala-kindled seizures. Brain Res. 1090 (2006) 202-207
39. Shouse M.N., da Silva A.M., and Sammaritano M. Circadian rhythm, sleep, and epilepsy. J. Clin. Neurophysiol. 13 (1996) 32-50
40. Shouse M.N., Scordato J.C., and Farber P.R. Sleep and arousal mechanisms in experimental epilepsy: epileptic components of NREM and antiepileptic components of REM sleep. Ment. Retard Dev. Disabil. Res. Rev. 10 (2004) 117-121
41. Stafstrom C.E. Epilepsy: a review of selected clinical syndromes and advances in basic science. J. Cereb. Blood Flow Metab. 26 (2006) 983-1004
42. Stone E.A., Cotecchia S., Lin Y., and Quartermain D. Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity. Synapse 46 (2002) 269-270
43. Swinyard E.A., Brown W.C., and Goodman L.S. Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. Exp. Ther. 106 (1952) 319-330
44. Szot P., Weinshenker D., Rho J.M., Storey T.W., and Schwartzkroin P.A. Norepinephrine is required for the anticonvulsant effect of the ketogenic diet. Brain Res.Dev. Brain Res. 129 (2001) 211-214
45. USMNSG. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54 (2000) 1166-1175
46. Velasco M., Velasco F., Velasco A.L., Jimenez F., Brito F., and Marquez I. Acute and chronic electrical stimulation of the centromedian thalamic nucleus: modulation of reticulo-cortical systems and predictor factors for generalized seizure control. Arch. Med. Res. 31 (2000) 304-315
47. Waller S.B., and Buterbaugh G.G. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development. Pharmacol. Biochem. Behav. 23 (1985) 473-478
48. Weinshenker D., and Szot P. The role of catecholamines in seizure susceptibility: new results using genetically engineered mice. Pharmacol. Ther. 94 (2002) 213-233
49. Wisor J.P., and Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
50. Wu X.H., Ding M.P., Zhu-Ge Z.B., Zhu Y.Y., Jin C.L., and Chen Z. Carnosine, a precursor of histidine, ameliorates pentylenetetrazole-induced kindled seizures in rat. Neurosci. Lett. 400 (2006) 146-149
51. Yokoyama H., Sato M., Iinuma K., Onodera K., and Watanabe T. Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats. Neurosci. Lett. 217 (1996) 194-196